Plasma Levels of Vasoactive Regulatory Peptides in Patients Receiving Regular Hemodialysis Treatment

References

• Katz, AI, Emmanouel S. Metabolism of polypeptide hormones by the normal kidney and in uremia. Nephron 1978; 22: 69–80.
   Google Scholar
• Shimamoto K. Watarai I, Miyahara M. A study of plasma vasopressin in patients undergoing chronic hemodialysis. J Clin Endocrinol Metab 1977; 45: 714–720.
   Google Scholar
• Hammer M, Dawids S, Bredgard Sörensen M, Christensen O, Ölgaard K. Hormonal response to volume depletion in non-nephrcctomised patients on regular haemodialysis. Proc Eur Dial Transplant Assoc 1979; 16: 252–258.
   Google Scholar
• Horký K, Srámkova J, Lachmanová J, Tomásck R, Dvoráková J. Plasma concentration of antidiuretic hormone in patients with chronic renal insufficiency on maintenance dialysis. Horm Metab Res 1979; 11: 241–246.
   Google Scholar
• Nord E, Danovitch GM. Vasopressin response in hacmodialysis patients. Proc Eur Dial Transplant Assoc 1979; 16: 238–243.
   Google Scholar
• Caillens H, Pruszczynski W, Meyrier A, Ang KS. Rousselet F, Ardaillou R. Relationship between change in volcmia at constant osmolality and plasma antidiuretic hormone. Miner Electrolyte Metab 1980; 4: 161–171.
   Google Scholar
• Benmansour M, Rainfray M. Paillard F, Ardaillou R. Metabolic clearance rate of immunorcactive vasopressin in man. Eur J Clin Invest 1982; 12: 475–480.
   Google Scholar
• Rauh W, Hund E, Sohl G, Rascher W, Mehls O, Schärer K. Vasoactive hormones in children with chronic renal failure. Kidney Int 1983; 24 (Suppl 15): S27-S33.
   Google Scholar
• Iitake K, Kimura T, Matsui K, Ota K, Shoji M, Inoue M, Yoshinaga K. Effect of hacmodialysis on plasma ADH levels, plasma renin activity and plasma aldosterone levels in patients with endstage renal disease. Acta Endocrinol (Copenh) 1985; 110: 207–213.
   Google Scholar
• Larochclle P, Béroniade V, Gutkowska J, Cusson JR, Lécrivain A, du Souich P, Cantin M, Genest J. Influence of hemodialysis on the plasma levels of the atrial natriuretic factor in chronic renal failure. Clin Invest Med 1987; 10: 350–354.
   Google Scholar
• Andersson U, Sylvén C, Lindvall K. Theodorsson E, Norée L-O. Cardiac function and cardiovascular hormone balance during hemodialysis with special reference to atrial natriuretic peptide. Clin Nephrol 1988; 30: 303–307.
   Google Scholar
• Rascher W, Tulassay T, Lang RE. Atrial natriuretic peptide in plasma of volume-overloaded children with chronic renal failure. Lancet 1985; ii: 303–305.
   Google Scholar
• Yamamoto Y, Higa T, Kitamura K, Tanaka K, Kangawa K, Matsuo H. Plasma concentrations of atrial natriuretic popypeptide in chronic hemodialysis patients. Regul Pept Suppl 1985; 4: 110–112.
   Google Scholar
• Anderson JV, Raine AEG, Proudler A, Bloom SR. Effect of haemodialysis on plasma concentrations of atrial natriuretic peptide in adult patients with chronic renal failure. J Endocrinol 1986; 110: 193–196.
   Google Scholar
• Eisenhauscr T, Talartschik J, Scheler F. Detection of fluid overload by plasma concentration of human atrial natriuretic peptide (h-ANP) in patients with renal failure. Klin Wochenschr 1986; 64 (Suppl VI): 68–72.
   Google Scholar
• Hasegawa K, Matsushita Y, Inoue T, Morii H, Ishibashi M, Yamaji T. Plasma levels of atrial natriuretic peptide in patients with chronic renal failure. J Clin Endocrinol Metab 1986; 63: 819–822.
   Google Scholar
• Nozuki M. Mouri T, Itoi K, Takahashi K, Totsune K, Saito T, Yoshinaga K. Plasma concentrations of atrial natriuretic peptide in various diseases. Tohoku J Exp Med 1986; 148: 439–447.
   Google Scholar
• Wilkins MR, Wood JA, Adu D, Lote CJ, Kendall MJ, Michael J. Change in plasma immunorcactive atrial natriuretic peptide during sequential ultrafiltration and haemodialysis. Clin SeH986; 71: 157–160.
   Google Scholar
• Zoccali C, Ciccarelli M, Mallamaci F, Salnitro F, Parlongo S, Maggiore Q. Effect of ultrafiltration on plasma concentrations of atrial natriuretic peptide in haemodialysis patients. Nephrol Dial Transplant 1986; 1: 188–191.
   Google Scholar
• Kurokawa S, Katoh Y, Sugiyama T, Kurosawa T, Takeda S, Sakamoto H, Marumo F, Kikawada R. Correlation of decreased plasma atrial natriuretic peptide level with left atrial diameter in chronic hemodialysis. Am J Cardiol 1987; 60: 1135.
   Google Scholar
• Ogawa K, Smith AI, Hodsman GP, Jackson B, Woodcock EA, Johnston CI. Plasma atrial natriuretic peptide: concentrations and circulating forms in normal man and patients with chronic renal failure. Clin Exp Pharmacol Physiol 1987; 14: 95–102.
   Google Scholar
• Shenker Y, Port FK, Swartz RD, Gross MD, Grekin RJ. Atrial natriuretic hormone secretion in patients with renal failure. Life SeH987; 41: 1635–1644.
   Google Scholar
• Saxenhofer H, Gnädinger MP, Weidmann P, Shaw S, Schohn D, Hess C, Uehlinger DE, Jahn H. Plasma levels and dialysancc of atrial natriuretic peptide in terminal renal failure. Kidney Int 1987; 32: 554–561.
   Google Scholar
• Walker RG, Swainson CP, Yandle TG, Nicholls MG, Espiner EA. Exaggerated responsiveness of immunoreactivc atrial natriuretic peptide to saline infusion in chronic renal failure. Clin SeH987; 72: 19–24.
   Google Scholar
• Yamamoto Y, Higa T, Kitamura K, Tanaka K, Kangawa K, Matsuo H. Plasma concentration of human atrial natriuretic polypeptide in patients with impaired renal function. Clin Nephrol 1987; 27: 84–86.
   Google Scholar
• Ando R, Matsuda O, Miyakc S, Yoshiyama N. Plasma levels of human atrial natriuretic factor in patients treated by hemodialysis and continuous ambulatory peritoneal dialysis. Nephron 1988; 50: 225–228.
   Google Scholar
• Cannella G, Albertini A, Assanelli D, Ghielmi S, Poiesi C, Gaggiotti M, Sandrini M, Visioli O. Maiorca R. Effects of changes in intravascular volume on atrial size and plasma levels of immunoreactive atrial natriuretic peptide in uremic man. Clin Nephrol 1988; 30: 187–192.
   Google Scholar
• Deray G, Maistre G, Basset JY, Cacoub P, Carayon A, Anouar M, Baumelou A, Legrand JC, Ancri D, Jacobs C. Plasma levels of atrial natriuretic peptide in chronically dialyzed patients. Kidney Int 1988; 34 (Suppl 25): S86-S88.
   Google Scholar
• Itoh H, Nakao K, Sugawara A, Saito Y, Mukoyama M, Morii N, Yamada T, Shiono S, Arai H, Hosoda K, Imura H. γ-Atrial natriuretic polypeptide (γANP)-derived peptides in human plasma: cosecretion of N-tcrminal γANP fragment and αANP. J Clin Endocrinol Mctab 1988; 67: 429–437.
   Google Scholar
• Jespersen B, Pedersen EB. Increased plasma levels of atrial natriuretic peptide in patients with chronic renal failure: effect of noradrenaline infusion. Nephrol Dial Transplant 1988; 3: 762–767.
   Google Scholar
• Morrissey EC, Wilner KD, Barager RR, Ward DM, Zicgler MG. Atrial natriuretic factor in renal failure and posthemodialytie postural hypotension. Am J Kidney Dis 1988; XII: 510–515.
   Google Scholar
• Petersen J, Li CC, Bishop-Abney N, Seniw CM. Hemodynamic and atrial natriuretic peptide responses to fluid removal and reinfusion in hemodialysis patients. Trans Am Soc Artif Intern Organs 1988; 34: 509–511.
   Google Scholar
• Sundsfjord JA, Thibault G, Larochelle P, Cantin M. Identification and plasma concentrations of the N-terminal fragment of proatrial natriuretic factor in man. J Clin Endocrinol Mctab 1988; 66: 605–610.
   Google Scholar
• Winters CJ, Sallman AL, Meadows J, Rico DM, Vesely DL. Two new hormones: Prohormone atrial natriuretic peptides 1–30 and 31–67 circulate in man. Biochem Biophys Res Commun 1988; 150: 231–236.
   Google Scholar
• Leunissen KML, Menheerc PPCA, Cheriex EC, van den Berg BW, Noordzij TC, van Hooff JP. Plasma alpha-human atrial natriuretic peptide and volume status in chronic haemodialysis patients. Nephrol Dial Transplant 1989; 4: 382–386.
   Google Scholar
• Rainc AEG, Bock A, Muller FB, Erne P, Bolli P, Brunncr F, Buhler FR. Comparative effects of haemodialysis and haemofiltration on plasma atrial natriuretic peptide. Nephrol Dial Transplant 1989; 4: 222–227.
   Google Scholar
• Odar-Cedcrlöf I, Theodorsson E, Eriksson C-G, Kjellstrand CM. Plasma concentrations of calcitonin generelated peptide increase during haemodialysis: relation to blood pressure. J Intern Med 1989; 226: 177–182.
   Google Scholar
• Aronin N, Krieger DT. Plasma immunoreactive β-endorphin is elevated in uraemia. Clin Endo-crinol (Oxf) 1983; 18: 459–464.
   Google Scholar
• Luger A, Lang I, Kovarik J, Stummvoll HK, Tempi H. Abnormalities in the hypothalamic-pituitary-adrenocortical axis in patients with chronic renal failure. Am J Kidney Dis 1987; IX: 51–54.
   Google Scholar
• Caruso U, Lezoche E, Mariani P, El1i M, Tisone G, Cravotto E, Casciani CU. Plasma levels of (β-endorphin in uraemic patients during hemodialysis. Int J Clin Pharmacol Res 1988; VIII: 17–20.
   Google Scholar
• Fitzgerald RD, Sunder-Plassmann G, Stoeken-huber F, Balcke P. β-Endorphin levels in patients with regular hemodialysis treatment. Kidney Int 1988; 33: 221.
   Google Scholar
• Elias AN, Vaziri ND, Maksy M. Plasma beta-endorphin and beta-lipotropin in patients with end-stage renal disease-effects of hemodialysis. Nephron 1986; 43: 173–176.
   Google Scholar
• Smith R, Grossman A, Gaillard R, Clement-Jones V, Ratter S, Mallinson J, Lowry PJ, Besser GM, Rees LH. Studies on circulating mct-enke-phalin and β-endorphin: normal subjects and patients with renal and adrenal disease. Clin Endocrinol (OxO 1981; 15: 291–300.
   Google Scholar
• Zoccali C, Ciccarelli M, Mallamaci F, Maggiore Q, Lotti M, Zucchelli GC. Plasma met-enkepha-lin and leu-enkephalin in chronic renal failure. Nephrol Dial Transplant 1987; 1: 219–222.
   Google Scholar
• Sirinek KR, O’Dorisio TM, Gaskill HV, Levine BA. Chronic renal failure: effect of hemodialysis on gastrointestinal hormones. Am J Surg 1984; 148: 732–735.
   Google Scholar
• Takahashi K, Mouri T, Itoi K, Sone M Ohneda M, Murakami O, Nozuki M. Tachibana Y, Yoshinaga K. Increased plasma immunoreactive neuropeptide Y concentrations in phaeochromo-cytoma and chronic renal failure. J Hypertens 1987; 5: 749–753.
   Google Scholar
• Doherty CC, Buchanan KD, Ardill J, McGeown MG. Elevations of gastrointestinal hormones in chronic renal failure. Proc Eur Dial Transplant Assoc 1978; 15: 456–465.
   Google Scholar
• Henriksen JH, Staun-Olsen P. Borg Mogensen N, Fahrenkrug J. Circulating endogenous vasoactive intestinal polypeptide (VIP) in patients with uraemia and liver cirrhosis. Eur J Clin Invest 1986; 16: 211–216.
   Google Scholar
• Viron B, Haddoum F, Michel C, Demailly F, Mignon F. Plasma vasoactive intestinal peptide in uremic patients. Int J Artif Organs 1989; 12: 276.
   Google Scholar
• Malangone JM, Abuelo JG, Pezzullo JC, Lund K, McGloin CA. Clinical and laboratory features of patients with chronic renal disease at the start of dialysis. Clin Nephrol 1989; 31: 77–87.
   Google Scholar
• Vertes V, Cangiano JL, Berman LB, Gould A. Hypertension in end-stage renal disease. N Engl J Med 1969; 280: 978–981.
   Google Scholar
• Rooke P, Baylis PH. A new sensitive radioimmunoassay for plasma arginine vasopressin. J Immunoassay 1982; 3: 115–131.
   Google Scholar
• Grunditz T, Ekman R, Håkanson R, Rerup C, Sundler F, Uddman R. Calcitonin gene-related peptide in thyroid nerve fibers and C cells. Effects on thyroid hormone secretion and calcium metabolism. Endoerinologv 1986; 119: 2313- 2324.
   Google Scholar
• Bramnert M, Ekman R, Larsson I, Thorell JI. Characterization and application of a radioimmunoassay for β-endorphin using an antiserum with negligible cross-reactivity against β-lipotro-pin. Regul Pept 1982; 5: 65–75.
   Google Scholar
• Winther Bach F, Ekman R, Molke Jensen F. Beta-endorphin-immunoreactive components in human cerebrospinal fluid. Regul Pcpt 1986: 16: 189–198.
   Google Scholar
• Ekman R, Bjartell A, Lisander B, Edvinsson L. γ2-MSH immunoreaetivity in the human heart. Life ScH989; 45: 787–792.
   Google Scholar
• Sjölund K, Ekman R, Akre F, Lindner P. Motilin in chronic idiopathic constipation. Scand J Gastroenterol 1986; 21: 914–918.
   Google Scholar
• Widerlöf E. Lindström LH, Wahlestedt C, Walleus H, Ekman R. Neuropeptide Y (NPY) and peptide Y (PYY) as possible cerebrospinal fluid markers for major depression and schizo-phrenia, respectively. J Psychiatr Res 1988; 22: 69–79.
   Google Scholar
• Brodin E, Lindcfors N. Dalsgaard C-J, Theodors-son-Norheim E, Rosell S. Tachykinin multiplicity in rat central nervous system as studied using antisera raised against substance P and neurokinin A. Regul Pept 1986; 13: 253–272.
   Google Scholar
• Wallengrcn J, Ekman R, Möllcr H. Substance P and vasoactive intestinal peptide in bullous and inflammatory skin disease. Acta Derm Venercol (Stockh) 1986; 66: 23–28.
   Google Scholar
• Davidson WD, Moore TC. Shippey W, Conovaloff AJ. Effect of bilateral nephrectomy and bilateral ureteral ligation on scrum gastrin levels in the rat. Gastroenterology 1974; 66: 522–525.
   Google Scholar
• Falcao HA, Wesdorp RIC, Fischer JE. Gastrin levels and gastric acid secretion in anephric patients and in patients with chronic and acute renal failure. J Surg Res 1975; 18: 107–111.
   Google Scholar
• Smith AG, Shuster S, Thody AJ, Alvarez-Ude F, Kerr DNS. Role of the kidney in regulating plasma immunorcactive bcta-mclanocytc-stimulat-ing hormone. BMJ 1976; 1: 874–876.
   Google Scholar
• Davidson WD. Springberg PD, Falkinburg NR. Renal extraction and excretion of endogenous gastrin in the dog. Gastroenterology 1973; 64: 955–961.
   Google Scholar
• Katz AI, Rubenstein AH. Metabolism of proinsulin, insulin and c-peptide in the rat. J Clin Invest 1973; 52: 1113–1121.
   Google Scholar
• Boden G, Master RW, Owen OE, Rudnick MR. Human pancreatic polypeptide in chronic renal failure and cirrhosis of the liver: role of kidneys and liver in pancreatic polypeptide metabolism. J Clin Endocrinol Metab 1980; 51: 573–578.
   Google Scholar
• Tang J, Webber RJ, Chang D, Chang JK, Kiang J, Wei ET. Depressor and natriuretic activities of several atrial peptides. Regul Pept 1984; 9:53–59.
   Google Scholar
• Weselcouch EO, Humphrey WR. Aiken JW. Effects of pulmonary and renal circulations on activity of atrial natriuretic factor. Am J Physiol 1985; 249: R595-R602.
   Google Scholar
• Richards AM, Cleland JGF, Tonolo G, Mclntyre GD, Leckic BJ. Dargie HJ, Ball SG, Robertson JIS. Plasma α natriuretic peptide in cardiac impairment. BMJ 1986; 293: 409–412.
   Google Scholar
• Luft FC, Lang RE, Aronoff GR, Ruskoaho H, Toth M, Ganten D, Sterzel RB, Unger T. Atriopeptin III kinetics and pharmacodynamics in normal and anephric rats. J Pharmacol Exp Ther 1986; 236: 416–418.
   Google Scholar
• Woolf AS, Simpson KL, Mansell MA, Moult PJA. The effect of renal transplantation on plasma atrial natriuretic peptide. Nephrol Dial Transplant 1988; 2: 205–208.
   Google Scholar
• Olins GM. Spear KL, Siegel NR. Zurchcr-Neely HA. Inactivation of atrial natriuretic factor by the renal brush border. Biochim Biophys Acta 1987; 901: 97–100.
   Google Scholar
• Stephenson SL, Kenny AJ. The hydrolysis of α-human atrial natriuretic peptide by pig kidney microvillar membranes is initiated by endopepti-dase-24.11. Biochem J 1987; 243: 183–187.
   Google Scholar
• Glass JD, Schwartz IL, Walter R. Enzymatic inactivation of peptide hormones possessing a C-terminal amide group. Proc Natl Acad Sci USA 1969; 63: 1426–1430.
   Google Scholar
• Benuck M, Berg MJ, Marks N. A distinct peptidyl dipeptidasc that degrades enkephalin: exceptionally high activity in rabbit kidney. Life ScH981; 28: 2643–2650.
   Google Scholar
• Stephenson SL, Kenny AJ. Metabolism of neuropeptides. Hydrolysis of angiotensins, bradykinins, substance P and oxytocin by pig kidney microvillar membranes. Biochem J 1987; 241: 237–247.
   Google Scholar
• Cowden AE, Baier J, Friesen HG. Direct stimulation of pituitary prolactin secretion by human uraemic serum. Proceedings of the 63rd Annual Meeting of the Endocrine Society 1981: 139.
   Google Scholar
• Blumbcrg A, Bürgi W. Behavior of β2-micro-globulin in patients with chronic renal failure undergoing hemodialysis, hemodiafiltration and continuous ambulatory peritoneal dialysis (CAPD). Clin Nephrol 1987; 27: 245–249.
   Google Scholar
• Thyscll H, Grubb A, Lindholm T, Ljunggren L, Mårtensson L. Cystatin C: a new marker of biocompatibility or a good marker for the redistribution of LMW proteins during hemodialysis? Trans Am Soc Artif Intern Organs 1988; 34: 202–204.
   Google Scholar
• Altura BM, Altura BT. Vascular smooth muscle and neurohypophyseal hormones. Fed Proc 1977; 36: 1853–1860.
   Google Scholar
• Giles TD, Sander GE, Rice JC, Quiroz AC. Systemic methionine-enkephalin evokes cardiostimulatory responses in the human. Peptides 1987; 8: 609–612.
   Google Scholar
• Pernow J, Lundberg JM, Kaijser L. Vasoconstrictor effects in vivo and plasma disappearance rate of neuropeptide Y in man. Life ScH987; 40: 47–54.
   Google Scholar
• Laragh JH, Atlas SA. Atrial natriuretic hormone: a regulator of blood pressure and volume homeostasis. Kidney Int 1988; 34 (Suppl 25): S64-S71.
   Google Scholar
• Rossi F, Lampa E, Berrino L, DiGiaimo A, Marmo E. Central and peripheral cardiovascular effects of β-endorphin in normotensive and spontaneously hypertensive rats and in rats rendered hypertensive by deoxycorticosterone acetate administration. Res Commun Chem Pathol Pharmacol 1987; 55: 181–192.
   Google Scholar
• Eimcrl J, Bayorh MA, Zukowska-Grojec Z, Feuerstein G. Motilin effects on the heart and blood vessels of the pithed rat. Neuropeptides 1985; 6: 157–164.
   Google Scholar
• Hua X, Lundberg JM. Theodorsson-Norheim E, Brodin E. Comparison of cardiovascular and bronchoconstrictor effects of substance P, substance K and other tachykinins. Naunyn Schmie-debergs Arch Pharmacol 1984; 328: 196–201.
   Google Scholar
• Domschke S, Domschke W. Biological actions of vasoactive intestinal peptide in man. In: Said DI, ed. Vasoactive intestinal peptide. New York: Raven Press, 1982: 201–209.
   Google Scholar